FindTrial
Sign In

Comparison of the Preventive Effect of Oliceridine and Sufentanil on Myoclonus Induced by Etomidate

Comparison of the Preventive Effect of Oliceridine and Sufentanil on Myoclonus Induced by Etomidate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100975
Enrollment
Unknown
Registered
2025-04-17
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoclonus

Interventions

Blank control group:Normal saline
Test group A:Sufentanil
Test group B:Oxeridine

Sponsors

The Third Affiliated Hospital of CQMU(Gener Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years old, ASAI-II grade, 2. BMI within the normal range, 3. General anesthesia at an appropriate time.

Exclusion criteria

Exclusion criteria: Patients with neuropsychological disorders; Adrenal cortical dysfunction; Heart failure; Kidney, lung, liver or endocrine diseases; History of allergy and abuse to etomidate and other investigatory drugs; Patients who had taken sedative and analgesic drugs on the day of surgery had cognitive impairment; Neuromuscular disease.

Design outcomes

Primary

MeasureTime frame
Incidence of Myoclonus ;Myoclonus intensity;Duration of Myoclonus;—

Countries

China

Contacts

Public ContactTingting Zou; Mingyuan Pan

The Third Affiliated Hospital of CQMU(Gener Hospital)

1035150216@qq.com+86 136 5766 9158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026